ANAB
ANAB
US0327241065
AnaptysBio, Inc.
Loading chart...
Elevated Business & Solvency Risk

Caution: In addition to price volatility, there are balance sheet risks due to higher debt or weaker liquidity (Health Score: 60/100).

Volatility Risk

Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.

Volatility Risk Score
7/7 Very High
7 / 7 SRI Price Fluctuation & Beta

Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves noticeably less than the broader market (0.5x).

Beta (Market Relation)
0.45x
Defensive
Volatility (5Y p.a.)
66.2% p.a.
5-Year Horizon
Max Drawdown (5Y)
-69.3%
5-Year Horizon
Sharpe Ratio
0.26
Return / Risk
Speculative / High Risk: Score Basis:

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

Volatility Expansion (3Y > 5Y) High Volatility
Timeframe
Volatility (p.a.)
Max Drawdown
Sharpe Ratio
Return (p.a.)
1 Year — — — +117.8%
3 Years 72.3% -69.3% 0.68 +51.5%
5 Years 66.2% -69.3% 0.26 +19.9%
10 Years 74.9% -92.1% 0.17 —

Automated Risk & Health Notes (Red Flags)

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Critical leverage: Debt-to-Equity is at 2547%.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Elevated Short-Term Volatility: 3Y volatility (72.3%) is noticeably higher than the 5Y average (66.2%).
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (66.2% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -92.1% in the extended horizon.

Corporate Governance & ISS Scores

Shareholder rights, board structure and audit safety (Scale 1 = Low Risk, 10 = High Risk)
Overall Governance Risk
7 ISS Score: 7 / 10
Audit Risk
5 ISS Score: 5 / 10
Board Risk
7 ISS Score: 7 / 10
Short Ratio
12.32
ende